Our professionals

Imagen del Dr. Ignacio Matos García, especialista en Oncología Médica de la Clínica Universidad de Navarra

Dr. Ignacio Matos

Medical Oncology Specialist

Works at: Madrid headquarters
Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra

Professional career

MD in Medicine and Surgery from the University of Oviedo (2009).

Board-certified specialist in Medical Oncology at Salamanca University Hospital (2015).

PhD in Medicine from the Autonomous University of Barcelona (2022).

University Master’s Degree in Supportive Treatments and Palliative Care in the Oncology Patient, University of Salamanca (2011–2012).

Post-specialization in gastrointestinal tumors and early-phase clinical trials. Medical Oncology Service, Vall d’Hebron University Hospital (2015–2017).

June 2017 – December 2019: Consultant Physician, Medical Oncology. Early Drug Development Unit, Vall d’Hebron University Hospital (2017–2019).

Expert Diploma in Immuno-Oncology from the University of Navarra (2017–2018).

Translational researcher in the “Immune Regulation & Tumour Immunotherapy” group (Professor Sergio Quezada), University College London Cancer Institute, London, United Kingdom (2020–2022).

RESEARCH AREAS

  • Co-investigator in more than 50 clinical trials.
  • Principal Investigator in more than 10 Phase I clinical trials.

Activity

In teaching

Assistant Professor:

  • 2012–2015: Medical Oncology course, School of Medicine, University of Salamanca.
  • 2018–2020: Master’s Program in Translational Biomedical Research, Autonomous University of Barcelona.
  • 2021: Expert Diploma in Precision Oncology, UFV Madrid. 

In research

  • Co-author of more than 30 scientific publications in national and international journals.
  • Co-author of more than 50 presentations at international conferences.
  • Clinical reviewer for the following journals: JCO Precision Oncology, British Journal of Cancer, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Frontiers in Cell and Developmental Biology, BMC Cancer, Future Oncology, eClinicalMedicine, and OncoTargets and Therapy.